Who Exports Mitoxantrone from India — 42 Suppliers Behind a $1.9M Market
India's mitoxantrone export market is supplied by 42 active exporters who collectively shipped $1.9M across 110 shipments. MVL GLOBAL leads with a 47.0% market share, followed by INTAS PHARMACEUTICALS LIMITED and MEDWISE OVERSEAS PRIVATE LIMITED. The top 5 suppliers together control 90.6% of total export value, reflecting a concentrated market structure.
Top Mitoxantrone Exporters from India — Ranked by Export Value
MVL GLOBAL is the leading mitoxantrone exporter from India, holding a 47.0% share of the $1.9M market across 110 shipments from 42 exporters. The top 5 suppliers — MVL GLOBAL, INTAS PHARMACEUTICALS LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED, CHANDRA BHAGAT PHARMA LIMITED — collectively control 90.6% of total export value, indicating a highly concentrated market. Individual shares are: MVL GLOBAL (47.0%), INTAS PHARMACEUTICALS LIMITED (37.1%), MEDWISE OVERSEAS PRIVATE LIMITED (4.0%), SP ACCURE LABS PRIVATE LIMITED (1.4%), CHANDRA BHAGAT PHARMA LIMITED (1.0%).
Top Mitoxantrone Exporters from India
Ranked by export value · 42 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MVL GLOBAL | $887.6K | 1 | 47.0% |
| 2 | INTAS PHARMACEUTICALS LIMITED NITROL 20MG INJ MITOXANTRONE | $701.0K | 4 | 37.1% |
| 3 | MEDWISE OVERSEAS PRIVATE LIMITED MEDOXANTRON 20PACK SIZE:1 X 10 ML VIALMEDOXANTRONE-20 (MITOXANTRONE CONCENTRATMITOXANTRONE INJECTION USP 20 MG 10 ML MITOXADN 20 | $76.3K | 1 | 4.0% |
| 4 | SP ACCURE LABS PRIVATE LIMITED MITO SPAL 20(MITOXANTRONE CONCENTRATE FO | $27.3K | 2 | 1.4% |
| 5 | CHANDRA BHAGAT PHARMA LIMITED PHARMACEUTICALS PRODUCT MITOXANTRONE FORMITOXANTRONE FOR INJECTION 20 MG/10ML (L | $18.3K | 2 | 1.0% |
| 6 | NEON LABORATORIES LIMITED | $11.2K | 1 | 0.6% |
| 7 | 3S CORPORATION | $6.3K | 2 | 0.3% |
| 8 | BIOZENTA LIFESCIENCE PRIVATE LIMITED MEDOXANTRON 20PACK SIZE:1 X 10 ML VIALMEDOXANTRONE-20 (MITOXANTRONE CONCENTRATMITOXANTRONE INJECTION USP 20 MG 10 ML MITOXADN 20 | $3.3K | 3 | 0.2% |
| 9 | RIZLIFE HEALTHCARE | $1.7K | 2 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Mitoxantrone exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Intas Pharmaceuticals Limited | Warning Letter, November | Yes, April 2007 | Yes | Not verified | Received FDA warning letter in November 2023 for CGMP violations; WHO-GMP certif |
TransData Nexus reviewed the regulatory standing of 1 leading Mitoxantrone exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Mitoxantrone sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This concentration of expertise and infrastructure makes Hyderabad a pivotal center for the manufacturing of complex drugs such as Mitoxantrone.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies like Intas Pharmaceuticals Limited, headquartered in Ahmedabad, play a significant role in this cluster. Intas Pharmaceuticals Limited accounted for 37.1% of Mitoxantrone exports, amounting to $0.7 million. The region's emphasis on finished dosage forms and formulations underscores its importance in the value-added segment of the pharmaceutical supply chain.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Companies such as Biozenta Lifescience Private Limited, based in Mumbai, contribute to the export of Mitoxantrone. Biozenta offers Mitoxantrone Injection USP 20 mg/10 ml, catering to international markets. The region's well-established logistics and port facilities facilitate efficient export operations, making it a strategic location for reaching global markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives and supportive infrastructure. This cluster hosts numerous manufacturing units specializing in various pharmaceutical products, including oncology medications like Mitoxantrone. The region's growth is bolstered by government initiatives aimed at enhancing production capabilities and export potential.
5Sourcing Recommendations
- Diversify Supplier Base: While MVL Global and Intas Pharmaceuticals Limited dominate Mitoxantrone exports, consider engaging with other manufacturers to mitigate supply risks.
- Leverage Cluster Specializations: Utilize the specific strengths of each pharmaceutical cluster—Hyderabad for bulk drug production, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics—to optimize sourcing strategies.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications, such as WHO-GMP, to maintain product integrity and facilitate market access.
- Assess Export Capabilities: Evaluate the export track record and logistical capabilities of potential suppliers to ensure timely and efficient delivery of Mitoxantrone to target markets.
By strategically analyzing India's pharmaceutical clusters and aligning sourcing strategies with their unique capabilities, TransData Nexus can enhance its supply chain resilience and optimize the procurement of Mitoxantrone.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Mitoxantrone exporters from India
INTAS PHARMACEUTICALS LIMITED — Intas Pharmaceuticals acquires Actavis UK & Ireland from Teva
Intas Pharmaceuticals completed the acquisition of Actavis UK Ltd. and Actavis Ireland Ltd. from Teva Pharmaceutical Industries Ltd. for an enterprise value of £603 million. This acquisition enhances Intas's presence in the European generic market and strengthens its position among the top global generic players. - IMPACT: The acquisition is expected to bolster Intas's manufacturing and distribution capabilities, potentially increasing its Mitoxantrone export capacity.
Impact: The acquisition is expected to bolster Intas's manufacturing and distribution capabilities, potentially increasing its Mitoxantrone export capacity.
Common Questions — Mitoxantrone Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which mitoxantrone supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MVL GLOBAL leads with 3 recorded shipments worth $887.6K. INTAS PHARMACEUTICALS LIMITED (13 shipments) and MEDWISE OVERSEAS PRIVATE LIMITED (3 shipments) are also established high-volume exporters.
Q How many mitoxantrone manufacturers are there in India?
India has 42 active mitoxantrone exporters with a combined export market of $1.9M across 110 shipments to 35 countries. The top 5 suppliers hold 90.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for mitoxantrone from India?
Average FOB unit price: $38.26 per unit, ranging from $1.05 to $1470.58. Average shipment value: $17.2K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 42 verified Indian exporters of Mitoxantrone ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 110 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 35 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
110 Verified Shipments
42 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists